Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Superantigen reactivity of gamma delta T cell clones isolated from patients with multiple sclerosis and controls.

Cellular immunology·1995
Same author

Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.

The American journal of pathology·1995
Same author

Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter.

Molecular and cellular biology·1995
Same author

A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity.

Nature genetics·1995
Same journal

Cardiovascular disease and miRNA.

Advances in clinical chemistry·2026
Same journal

RNA biomarkers in antidoping.

Advances in clinical chemistry·2026
Same journal

Biomarkers for assessing magnesium status.

Advances in clinical chemistry·2026
Same journal

Advances in microfluidic extracellular vesicle technology.

Advances in clinical chemistry·2026
Same journal

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Advances in clinical chemistry·2026
Same journal

Biomarkers in heart failure.

Advances in clinical chemistry·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

27.3K

Circulating Tumor Cell Isolation and Analysis.

J Zhang1, K Chen1, Z H Fan1

  • 1University of Florida, Gainesville, FL, United States.

Advances in Clinical Chemistry
|June 28, 2016
PubMed
Summary
This summary is machine-generated.

This review highlights microfluidic devices for efficiently isolating rare circulating tumor cells (CTCs) from bodily fluids. These advanced methods improve cancer diagnosis, treatment monitoring, and metastasis risk assessment.

Keywords:
BiomarkersCancerCirculating tumor cellsDiagnosisMicrofluidics

More Related Videos

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

9.2K
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.7K

Related Experiment Videos

Last Updated: Mar 18, 2026

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

27.3K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

9.2K
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.7K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cell Biology

Background:

  • Circulating tumor cells (CTCs) are crucial biomarkers for cancer metastasis, diagnosis, and treatment monitoring.
  • Their rarity in bodily fluids presents significant isolation and analysis challenges.
  • Traditional purification techniques often suffer from low recovery rates.

Purpose of the Study:

  • To review recent advancements in microfluidic devices for CTC isolation and analysis.
  • To discuss the clinical applications of these advanced CTC detection methods.
  • To highlight the potential of microfluidics in overcoming current CTC isolation limitations.

Main Methods:

  • Review of microfluidic device designs and principles for CTC enrichment.
  • Analysis of various detection and characterization techniques for isolated CTCs.
  • Compilation of recent clinical studies utilizing microfluidic-based CTC analysis.

Main Results:

  • Microfluidic devices demonstrate high efficiency, sensitivity, and throughput for CTC isolation.
  • These platforms effectively process complex biological samples like peripheral blood.
  • Recent studies show promising clinical utility in diagnosis, prognosis, and treatment response evaluation.

Conclusions:

  • Microfluidic technology offers a promising solution for overcoming the challenges of CTC isolation.
  • Advanced CTC analysis via microfluidics can significantly impact cancer patient management.
  • Further integration into clinical practice is expected to enhance cancer care outcomes.